The safety and efficacy of prednisolone in preventing reaccumulation of ascites among endomyocardial fibrosis patients in Uganda: a randomized clinical trial
暂无分享，去创建一个
[1] M. Yacoub,et al. Presence of Circulating Anti-Myosin Antibodies in Endomyocardial Fibrosis , 2010, PLoS neglected tropical diseases.
[2] M. Yacoub,et al. A population study of endomyocardial fibrosis in a rural area of Mozambique. , 2008, The New England journal of medicine.
[3] M. Yacoub,et al. Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis , 2008, Heart.
[4] Frieder Keller,et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids , 2005, Clinical Pharmacokinetics.
[5] R. Moreau,et al. The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club , 2003, Hepatology.
[6] H. Mayanja-Kizza,et al. Endomyocardial fibrosis syndrome in Uganda , 2000, The Lancet.
[7] R. Mugerwa,et al. Tropical endomyocardial fibrosis in Uganda: the tribal and geographic distribution, and the association with eosinophilia. , 2000 .
[8] J. Ziegler,et al. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda , 1999, Tropical medicine & international health : TM & IH.
[9] C. Sezi. Effect of protein deficient cassava diet on Cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man. , 1996, East African medical journal.
[10] H. Mayanja-Kizza,et al. Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? , 1996, The Lancet.